Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats
Authors:
- Satomi OnoueSatomi Onoue
- Hideyuki SatoHSHideyuki Sato
- Kumiko OgawaKOKumiko Ogawa
- Yoshiki KojoYKYoshiki Kojo
- Yosuke AokiYAYosuke Aoki
- Yohei KawabataYKYohei Kawabata
- Koichi WadaKWKoichi Wada
- Takahiro MizumotoTMTakahiro Mizumoto
- Shizuo YamadaSYShizuo Yamada
- 1 January 2012
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 80 (1) , 54-60
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approachInternational Journal of Pharmaceutics, 2010
- In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapyJournal of Controlled Release, 2009
- Characterization of a new inhalable thymopentin formulationInternational Journal of Pharmaceutics, 2009
- Dry powder inhalation systems for pulmonary delivery of therapeutic peptides and proteinsExpert Opinion on Therapeutic Patents, 2008
- Total and differential leucocyte counts in rat and mouse bronchoalveolar lavage fluids using the Sysmex XT-2000iVComparative Clinical Pathology, 2006
- Inhalation drug delivery devices and emerging technologiesExpert Opinion on Therapeutic Patents, 2003
- Nebulizer-Compatible Liquid Formulations for Aerosol Pulmonary Delivery of Hydrophobic Drugs: Glucocorticoids and CyclosporineJournal of Drug Targeting, 1999
- Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: Correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics*Surgery, 1995
- Is there a role for cyclosporine in asthma?Journal of Allergy and Clinical Immunology, 1992
- Cyclosporin for steroid‐dependent asthmaAllergy, 1991